Related Experiment Video
Updated: Jul 13, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Low penicillin susceptibility in Streptococcus mitis/oralis from bloodstream infections in pediatric populations
Jian-Ming Zhou1, Cai-Yu Wu2, Jian-Ping Li1
1Department of Clinical Laboratory, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, Zhejiang, China.
Abstract:
Streptococcus mitis/oralis can cause invasive diseases, including bloodstream infections. However, existing research primarily focuses on specific populations, and limited studies have been conducted on the prevalence of bloodstream infection caused by S. mitis/oralis across the entire pediatric population. Therefore, clinical data of S. mitis/oralis isolated from blood samples at Children's Hospital, Zhejiang University School of Medicine, during the period 2019-2023 were collected retrospectively to provide a comprehensive understanding of the clinical characteristics and drug resistance patterns associated with bloodstream infections caused by S. mitis/oralis in pediatric populations. There were 57 (43.5%) instances of contamination across various departments, indicating a relatively dispersed pattern. Bloodstream infections caused by S. mitis/oralis are notably prevalent among pediatric patients with hematological diseases and tumors. The susceptibility rates of the 74 S. mitis/oralis isolates to different antibiotics were as follows: penicillin (23%), ceftriaxone (74.3%), levofloxacin (86.5%), chloramphenicol (89.2%), erythromycin (27%), clindamycin (67.6%), linezolid (100%), and vancomycin (100%). Notably, 21.6% of the isolates exhibited multi-drug resistance (MDR). The predominant mode of MDR in S. mitis/oralis infections was identified as resistance to β-lactams, erythromycin, and clindamycin. The observed low susceptibility rate to penicillin, coupled with the emergence of MDR strains, underscores the imperative for continuous monitoring of the evolving antimicrobial resistance in S. mitis/oralis.
Importance:
Existing research primarily focuses on specific populations, such as those with hematopathy or tumors, who experience Streptococcus mitis/oralis bacteremia. Limited studies have been conducted on the prevalence of bloodstream infections caused by S. mitis/oralis across the entire pediatric population. It was found that the contamination rate of S. mitis/oralis isolated from blood cultures was notably high in our study. Therefore, this study evaluated the clinical characteristics and drug resistance patterns of bloodstream infections caused by S. mitis/oralis across the entire pediatric populations, explicitly excluding cases of blood culture contamination. The observed low susceptibility rate to penicillin, coupled with the emergence of multi-drug-resistant strains, underscores the imperative for continuous monitoring of the evolving antimicrobial resistance in S. mitis/oralis.
Insights
Streptococcus mitis/oralis bloodstream infections are common in pediatric patients with hematological diseases and tumors. A significant percentage of these infections are multi-drug resistant, necessitating ongoing monitoring of antimicrobial resistance patterns.
Area of Science:
- Microbiology
- Infectious Diseases
- Pediatrics
Background:
- Streptococcus mitis/oralis can cause invasive diseases, including bloodstream infections.
- Existing research often focuses on specific pediatric subgroups, lacking a comprehensive view of S. mitis/oralis bloodstream infections across the general pediatric population.
- High contamination rates in blood cultures can complicate accurate diagnosis.
Purpose of the Study:
- To evaluate the clinical characteristics and antimicrobial resistance patterns of bloodstream infections caused by Streptococcus mitis/oralis in a broad pediatric population.
- To specifically exclude blood culture contamination cases for a clearer understanding of true infections.
- To highlight the need for continuous monitoring of antimicrobial resistance in S. mitis/oralis.
Main Methods:
- Retrospective collection of clinical data for S. mitis/oralis isolates from blood samples.
- Analysis of patient demographics, clinical characteristics, and antibiotic susceptibility testing results.
- Exclusion of blood culture contamination cases from the analysis.
Main Results:
- Bloodstream infections caused by S. mitis/oralis were most prevalent in pediatric patients with hematological diseases and tumors.
- Susceptibility rates varied significantly, with low rates for penicillin (23%) and erythromycin (27%).
- 21.6% of isolates exhibited multi-drug resistance (MDR), predominantly to beta-lactams, erythromycin, and clindamycin. Linezolid and vancomycin showed 100% susceptibility.
Conclusions:
- Streptococcus mitis/oralis bloodstream infections present a significant challenge in pediatric populations, particularly in immunocompromised patients.
- The emergence of multi-drug resistant strains, especially resistance to penicillin, necessitates careful antibiotic selection and stewardship.
- Continuous surveillance of antimicrobial resistance patterns is crucial for effective management of S. mitis/oralis infections.
More Related Videos
Related Concept Videos
Production of Antibiotics
Development of the Oral Microbiota
Microbiota of the Respiratory Tract
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Clinical Significance of Antibiotic Resistance

